Kite to Present at June 2017 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq: KITE), a leading cell therapy company, today announced that management will present at two investor conferences in June 2017:

• Jefferies 2017 Global Healthcare ConferenceWednesday, June 71:30pm Eastern TimeNew York, NY
• Goldman Sachs 38th Annual Global Healthcare ConferenceTuesday, June 132:00pm Pacific TimeRancho Palos Verdes, CA

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170606005247/en/

Kite
Christine Cassiano
SVP, Corporate Communications & Investor Relations
[email protected]
or
Greg Mann
VP, Investor Relations
[email protected]

Source: Kite Pharma, Inc.

You May Also Be Interested In

• Financial Scam Recovery Australia with Disective: A Guide to Protecting Your Finances
• Tiled Roof Restoration Services Expand Across Melbourne's West
• Beyond the Credential: As AI Erases the 'Entry-Level Job' and Climate Volatility Accelerates, Planet Classroom Unveils July Lineup Mapping the New Rules of Human Resilience